We are aware that a message is circulating on local social media suggesting that Tirzepatide (Mounjaro) will be available for weight loss prescriptions from GPs starting 23rd June. As a result, we have received a high volume of enquiries.
Please note that while the guidance refers to ‘primary care’, this does not mean individual GP practices. We have been explicitly advised not to prescribe this medication.
Find out more about Mounjaro (Tirzepatide) access in Cheshire and Merseyside on the ICB website.
What is changing in the management of obesity? People in England over the age of 18 living with obesity and…
The UK Health Security Agency (UKHSA) has reported a significant increase in measles cases in the UK, with the West…